NM_000419.5:c.409-2_419delAGGCCTGCGCCCC
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PP4_StrongPM3PM2_SupportingPS3PVS1_Strong
This summary comes from the ClinGen Evidence Repository: The c.409-2_419del variant was first reported in the Palestinian population by PMID:2014236; haplotype analysis in PMID:16359514 is consistent with a founder effect. This variant has also been described as c.409-3_418del and HGVS nomenclature is c.409-4_417del. The deletion causes use of a cryptic splice site at position c.425_426 (confirmed in patient mRNA in PMID:2014236). As such there is an in-frame deletion of 18bp encompassing 6 amino acids (Ala137 through Gln142) in the critical ligand binding beta-propeller domain. This variant is absent from all population databases, including gnomAD. The variant has been identified homozygous in at least 8 patients (PMIDs: 2014236, 16359514). with a phenotype highly specific to GT. Transfection in BHK cells resulted in lack of surface expression of αIIbβ3 (PMID:16359514). In summary this variant is classified as Pathogenic for GT. GT-specific criteria applied: PVS1_strong, PS3, PM2_supporting, PM3, PP4_strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10575471/MONDO:0010119/011
Frequency
Consequence
NM_000419.5 frameshift, splice_acceptor, splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- platelet-type bleeding disorder 16Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Glanzmann thrombastheniaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Glanzmann's thrombastheniaInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- Glanzmann thrombasthenia 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant macrothrombocytopeniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000419.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ITGA2B | NM_000419.5 | MANE Select | c.409-2_419delAGGCCTGCGCCCC | p.Ala137fs | frameshift splice_acceptor splice_region intron | Exon 4 of 30 | NP_000410.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ITGA2B | ENST00000262407.6 | TSL:1 MANE Select | c.409-2_419delAGGCCTGCGCCCC | p.Ala137fs | frameshift splice_acceptor splice_region intron | Exon 4 of 30 | ENSP00000262407.5 | ||
| ITGA2B | ENST00000592944.1 | TSL:5 | n.92_104delAGGCCTGCGCCCC | non_coding_transcript_exon | Exon 1 of 6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at